Hohimer Wealth Management, LLC Acadia Pharmaceuticals Inc Transaction History

Hohimer Wealth Management, LLC

  • $419 Million
  • Q1 2024

A detailed history of Hohimer Wealth Management, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Hohimer Wealth Management, LLC holds 17,133 shares of ACAD stock, worth $271,386. This represents 0.08% of its overall portfolio holdings.

Number of Shares
17,133
Previous 17,133 -0.0%
Holding current value
$271,386
Previous $536,000 41.04%
% of portfolio
0.08%
Previous 0.14%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 20, 2023
SELL
$20.84 - $33.47 $15,630 - $25,102
-750 Reduced 4.19%
17,133 $357,000
Q2 2023

Jul 27, 2023
SELL
$17.8 - $25.65 $42,399 - $61,098
-2,382 Reduced 11.75%
17,883 $428,000
Q4 2022

Feb 01, 2023
BUY
$14.2 - $18.63 $60,350 - $79,177
4,250 Added 26.54%
20,265 $322,000
Q3 2022

Nov 02, 2022
SELL
$14.11 - $18.27 $7,055 - $9,135
-500 Reduced 3.03%
16,015 $262,000
Q3 2021

Oct 18, 2021
BUY
$15.78 - $24.77 $31,244 - $49,044
1,980 Added 13.62%
16,515 $274,000
Q2 2021

Jul 12, 2021
BUY
$19.4 - $27.42 $281,979 - $398,549
14,535 New
14,535 $355,000
Q1 2021

Apr 12, 2021
SELL
$25.02 - $54.99 $96,702 - $212,536
-3,865 Closed
0 $0
Q4 2020

Jan 11, 2021
BUY
$41.04 - $56.79 $158,619 - $219,493
3,865 New
3,865 $207,000
Q3 2020

Nov 13, 2020
SELL
$36.42 - $57.0 $231,813 - $362,805
-6,365 Closed
0 $0
Q2 2020

Jul 14, 2020
BUY
$39.26 - $52.73 $98,150 - $131,825
2,500 Added 64.68%
6,365 $309,000
Q1 2020

May 05, 2020
SELL
$31.65 - $46.87 $284,850 - $421,830
-9,000 Reduced 69.96%
3,865 $201,000
Q4 2019

Feb 14, 2020
BUY
$36.21 - $51.4 $465,841 - $661,261
12,865 New
12,865 $550,000

Others Institutions Holding ACAD

# of Institutions
299
Shares Held
158M
Call Options Held
1.88M
Put Options Held
688K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.56B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Hohimer Wealth Management, LLC Portfolio

Follow Hohimer Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hohimer Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hohimer Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email